Seoul, South Korea

Dae Ro Ahn

This inventor holds 4 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Korea Institute of Science and Technology. Active years: 2017-2022.

USPTO Granted Patents = 4 

% Patents Active = 75.0

 

Average Co-Inventor Count = 2.6

ph-index = 1


Location History:

  • Paju-si, KR (2017)
  • Seoul, KR (2020 - 2022)

Company Filing History:


Years Active: 2017-2022

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Dae Ro Ahn: Innovator in Drug Delivery Technologies

Introduction

Dae Ro Ahn is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of drug delivery technologies, holding a total of 4 patents. His work focuses on innovative methods for delivering therapeutic agents and imaging probes to specific cells and tissues.

Latest Patents

One of his latest patents is titled "Drug carrier having self-assembled 3-D nucleic acid nanostructure." This invention relates to a molecule delivery technology that selectively delivers materials to desired specific cells and living tissues. It has potential applications in effectively delivering imaging probes and therapeutic agents to affected areas. Another notable patent is "Self-assembled ribonucleoprotein nanoparticles." This patent provides a self-assembled polyribonucleotide-protein complex that includes a polyribonucleotide with a single guide RNA (sgRNA) region and a small interfering RNA (siRNA) region, along with one or more nuclease proteins binding to the sgRNA region.

Career Highlights

Dae Ro Ahn is affiliated with the Korea Institute of Science and Technology, where he continues to advance research in his field. His innovative approaches have garnered attention and recognition within the scientific community.

Collaborations

Some of his notable coworkers include Se Hoon Kim and Kyoung Ran Kim, who have collaborated with him on various projects.

Conclusion

Dae Ro Ahn's contributions to drug delivery technologies exemplify the impact of innovative thinking in the medical field. His patents reflect a commitment to improving therapeutic delivery systems, which could lead to significant advancements in healthcare.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…